US Stock MarketDetailed Quotes

NMRA Neumora Therapeutics

Watchlist
  • 9.740
  • +0.050+0.52%
Close Nov 22 16:00 ET
  • 9.740
  • 0.0000.00%
Post 20:01 ET
1.57BMarket Cap8.77P/E (TTM)

Neumora Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
34.79%76.65M
51.73%63.82M
53.38%60.07M
85.54%252.1M
271.13%114M
85.82%56.86M
34.32%42.06M
-9.41%39.17M
-42.75%135.87M
15.71%30.72M
Selling and administrative expenses
4.93%16.02M
63.50%15.19M
47.86%14.32M
46.12%45.48M
56.16%11.24M
89.53%15.26M
19.36%9.29M
19.74%9.68M
26.78%31.12M
-5.80%7.2M
-General and administrative expense
4.93%16.02M
63.50%15.19M
47.86%14.32M
46.12%45.48M
56.16%11.24M
89.53%15.26M
19.36%9.29M
19.74%9.68M
26.78%31.12M
-5.80%7.2M
Research and development costs
45.74%60.63M
48.40%48.63M
55.19%45.76M
97.26%206.62M
336.88%102.77M
84.49%41.6M
39.28%32.77M
-16.11%29.49M
-50.77%104.75M
24.40%23.52M
Operating profit
-34.79%-76.65M
-51.73%-63.82M
-53.38%-60.07M
-85.54%-252.1M
-271.13%-114M
-85.82%-56.86M
-34.32%-42.06M
9.41%-39.17M
42.75%-135.87M
-15.71%-30.72M
Net non-operating interest income expense
9.67%4.21M
48.15%5.27M
78.34%6.37M
264.20%16.61M
147.09%5.65M
172.97%3.84M
353.83%3.56M
4,050.00%3.57M
4.56M
2.29M
Non-operating interest income
9.67%4.21M
48.15%5.27M
78.34%6.37M
264.20%16.61M
147.09%5.65M
172.97%3.84M
353.83%3.56M
4,050.00%3.57M
--4.56M
--2.29M
Other net income (expense)
-5,600.00%-57K
38.46%-24K
53.85%-12K
-141.98%-170K
-136.24%-104K
99.32%-1K
-124.68%-39K
-124.07%-26K
3,581.82%405K
168.01%287K
Other non- operating income (expenses)
-5,600.00%-57K
38.46%-24K
53.85%-12K
-141.98%-170K
-136.24%-104K
99.32%-1K
-124.68%-39K
-124.07%-26K
3,581.82%405K
168.01%287K
Income before tax
-36.71%-72.49M
-51.97%-58.58M
-50.80%-53.72M
-80.02%-235.66M
-285.35%-108.46M
-80.71%-53.03M
-26.90%-38.54M
17.23%-35.63M
44.84%-130.9M
-4.36%-28.15M
Income tax
53K
125K
268K
268K
0
0
0
Net income
-36.81%-72.55M
-52.30%-58.7M
-50.80%-53.72M
-80.23%-235.93M
-286.31%-108.73M
-80.71%-53.03M
-26.90%-38.54M
17.23%-35.63M
44.84%-130.9M
-4.36%-28.15M
Net income continuous Operations
-36.81%-72.55M
-52.30%-58.7M
-50.80%-53.72M
-80.23%-235.93M
-286.31%-108.73M
-80.71%-53.03M
-26.90%-38.54M
17.23%-35.63M
44.84%-130.9M
-4.36%-28.15M
Minority interest income
Net income attributable to the parent company
-36.81%-72.55M
-52.30%-58.7M
-50.80%-53.72M
-80.23%-235.93M
-286.31%-108.73M
-80.71%-53.03M
-26.90%-38.54M
17.23%-35.63M
44.84%-130.9M
-4.36%-28.15M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-36.81%-72.55M
-52.30%-58.7M
-50.80%-53.72M
-80.23%-235.93M
-286.31%-108.73M
-80.71%-53.03M
-26.90%-38.54M
17.23%-35.63M
44.84%-130.9M
-4.36%-28.15M
Basic earnings per share
60.53%-0.45
-45.87%-0.37
-45.02%-0.34
24.53%-3.63
-269.57%-0.6846
-490.32%-1.14
-26.90%-0.2537
17.23%-0.2345
-207.98%-4.81
-4.36%-0.1852
Diluted earnings per share
60.53%-0.45
-45.87%-0.37
-45.02%-0.34
24.53%-3.63
-269.57%-0.6846
-490.32%-1.14
-26.90%-0.2537
17.23%-0.2345
-207.98%-4.81
-4.36%-0.1852
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 34.79%76.65M51.73%63.82M53.38%60.07M85.54%252.1M271.13%114M85.82%56.86M34.32%42.06M-9.41%39.17M-42.75%135.87M15.71%30.72M
Selling and administrative expenses 4.93%16.02M63.50%15.19M47.86%14.32M46.12%45.48M56.16%11.24M89.53%15.26M19.36%9.29M19.74%9.68M26.78%31.12M-5.80%7.2M
-General and administrative expense 4.93%16.02M63.50%15.19M47.86%14.32M46.12%45.48M56.16%11.24M89.53%15.26M19.36%9.29M19.74%9.68M26.78%31.12M-5.80%7.2M
Research and development costs 45.74%60.63M48.40%48.63M55.19%45.76M97.26%206.62M336.88%102.77M84.49%41.6M39.28%32.77M-16.11%29.49M-50.77%104.75M24.40%23.52M
Operating profit -34.79%-76.65M-51.73%-63.82M-53.38%-60.07M-85.54%-252.1M-271.13%-114M-85.82%-56.86M-34.32%-42.06M9.41%-39.17M42.75%-135.87M-15.71%-30.72M
Net non-operating interest income expense 9.67%4.21M48.15%5.27M78.34%6.37M264.20%16.61M147.09%5.65M172.97%3.84M353.83%3.56M4,050.00%3.57M4.56M2.29M
Non-operating interest income 9.67%4.21M48.15%5.27M78.34%6.37M264.20%16.61M147.09%5.65M172.97%3.84M353.83%3.56M4,050.00%3.57M--4.56M--2.29M
Other net income (expense) -5,600.00%-57K38.46%-24K53.85%-12K-141.98%-170K-136.24%-104K99.32%-1K-124.68%-39K-124.07%-26K3,581.82%405K168.01%287K
Other non- operating income (expenses) -5,600.00%-57K38.46%-24K53.85%-12K-141.98%-170K-136.24%-104K99.32%-1K-124.68%-39K-124.07%-26K3,581.82%405K168.01%287K
Income before tax -36.71%-72.49M-51.97%-58.58M-50.80%-53.72M-80.02%-235.66M-285.35%-108.46M-80.71%-53.03M-26.90%-38.54M17.23%-35.63M44.84%-130.9M-4.36%-28.15M
Income tax 53K125K268K268K000
Net income -36.81%-72.55M-52.30%-58.7M-50.80%-53.72M-80.23%-235.93M-286.31%-108.73M-80.71%-53.03M-26.90%-38.54M17.23%-35.63M44.84%-130.9M-4.36%-28.15M
Net income continuous Operations -36.81%-72.55M-52.30%-58.7M-50.80%-53.72M-80.23%-235.93M-286.31%-108.73M-80.71%-53.03M-26.90%-38.54M17.23%-35.63M44.84%-130.9M-4.36%-28.15M
Minority interest income
Net income attributable to the parent company -36.81%-72.55M-52.30%-58.7M-50.80%-53.72M-80.23%-235.93M-286.31%-108.73M-80.71%-53.03M-26.90%-38.54M17.23%-35.63M44.84%-130.9M-4.36%-28.15M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -36.81%-72.55M-52.30%-58.7M-50.80%-53.72M-80.23%-235.93M-286.31%-108.73M-80.71%-53.03M-26.90%-38.54M17.23%-35.63M44.84%-130.9M-4.36%-28.15M
Basic earnings per share 60.53%-0.45-45.87%-0.37-45.02%-0.3424.53%-3.63-269.57%-0.6846-490.32%-1.14-26.90%-0.253717.23%-0.2345-207.98%-4.81-4.36%-0.1852
Diluted earnings per share 60.53%-0.45-45.87%-0.37-45.02%-0.3424.53%-3.63-269.57%-0.6846-490.32%-1.14-26.90%-0.253717.23%-0.2345-207.98%-4.81-4.36%-0.1852
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data